Table 4.
Monoclonal antibodies characterization and testing of passive protection
MAbs |
Intracellulara |
Surface associatedb |
IFAc |
Affinity KD (nM)d |
MAb binding domaine |
% Mice survival ratef |
|
---|---|---|---|---|---|---|---|
JEV Dengue 2 V | |||||||
3E10 |
+ |
+ |
+ |
- |
1.1 |
unknown |
16 |
4 C4 |
+ |
+ |
+ |
+ |
56 |
NS11–143 |
33 |
7 C2 |
+ |
+ |
+ |
+ |
17 |
NS1224–352 |
8 |
7 H5 |
+ |
+ |
+ |
+ |
6.4 |
NS1224–352 |
0 |
8 F1 | + | + | + | + | 5 | NS1224–352 | 0 |
a/bMAbs were incubated with S2-NS11–352 cells permeabilized or untreated (intracellular/surface associate) for fluorescence testing by flow cytometry (FACScan).
c Immunofluorescence assay (IFA) for testing monoclonal antibodies reactivity against BHK cells infected with JEV, and C6/36 cells infected with Dengue 2 virus.
d The affinity of MAbs to NS1 tested by surface plasmon resonance (SPR).
e Reactivity of MAbs for S2- NS11–143 or NS1224–352 fragments. Cells lysates were tested by Western blotting (WB). “Unknown” means did not react with both of the NS1 fragments or reduced and boiled NS1.
f Six to twelve mice were administered with 100μg of 3E10, 4 C4, 7 C2 and 8 F1, respectively, and challenged by JEV SA14.